Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italy again extends deadline for registering products on medtech database

This article was originally published in RAJ Devices

Executive Summary

The Italian health ministry has for the second time extended the deadline – this time to 31 December 2009 – for medical device manufacturers to re-register their products onto the Repertorio database1. The re-registration is mandatory for all medical devices that were on the market when the new, controversial, registration requirements came into force in May 20072.

You may also be interested in...



Pharma Guidelines, ending 1 July 2011

Recently updated and newly issued documents

EuropaBio appoints new chairman

EuropaBio, the European biotech industry association, has appointed Stephan Tanda as its new association chair. Mr Tanda, a member of the managing board of life sciences and materials sciences firm DSM, succeeds GlaxoSmithKline's Andrea Rappagliosi, who will remain a member of the EuropaBio board.

Medtech Guidelines, ending 24 June 2011

Recently updated and newly issued documents

Latest Headlines
See All
UsernamePublicRestriction

Register

SC095227

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel